Home LiteratureArticle Details
PMID: 14685937 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign.

American journal of human genetics ·Vol. 74 ·No. 1 ·2004-01-00 ·Pages 176-9

Groman JD, Hefferon TW, Casals T, Bassas L, Estivill X, Des Georges M, Guittard C, Koudova M, Fallin MD, Nemeth K, Fekete G, Kadasi L, Friedman K, Schwarz M, Bombieri C, Pignatti PF, Kanavakis E, Tzetis M, Schwartz M, Novelli G, D'Apice MR, Sobczynska-Tomaszewska A, Bal J, Stuhrmann M, Macek M, Claustres M, Cutting GR

Abstract

An abbreviated tract of five thymidines (5T) in intron 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is found in approximately 10% of individuals in the general population. When found in trans with a severe CFTR mutation, 5T can result in male infertility, nonclassic cystic fibrosis, or a normal phenotype. To test whether the number of TG repeats adjacent to 5T influences disease penetrance, we determined TG repeat number in 98 patients with male infertility due to congenital absence of the vas deferens, 9 patients with nonclassic CF, and 27 unaffected individuals (fertile men). Each of the individuals in this study had a severe CFTR mutation on one CFTR gene and 5T on the other. Of the unaffected individuals, 78% (21 of 27) had 5T adjacent to 11 TG repeats, compared with 9% (10 of 107) of affected individuals. Conversely, 91% (97 of 107) of affected individuals had 12 or 13 TG repeats, versus only 22% (6 of 27) of unaffected individuals (P<.00001). Those individuals with 5T adjacent to either 12 or 13 TG repeats were substantially more likely to exhibit an abnormal phenotype than those with 5T adjacent to 11 TG repeats (odds ratio 34.0, 95% CI 11.1-103.7, P<.00001). Thus, determination of TG repeat number will allow for more accurate prediction of benign versus pathogenic 5T alleles.

MeSH Terms
Base Sequence Cystic Fibrosis/genetics Cystic Fibrosis Transmembrane Conductance Regulator/genetics Dinucleotide Repeats/genetics Genetic Variation/genetics Genotype Humans Male Mutation/genetics Phenotype Reference Values
Chemicals
CFTR protein, human Cystic Fibrosis Transmembrane Conductance Regulator
Authors & Affiliations
27 authors, click to expand affiliations / ORCID
Groman Joshua D
Training Program in Human Genetics, McKusick-Nathans Institute of Genetic Medicine, Baltimore, MD 21287, USA.
Hefferon Timothy W
Casals Teresa
Bassas Lluís
Estivill Xavier
Des Georges Marie
Guittard Caroline
Koudova Monika
Fallin M Daniele
Nemeth Krisztina
Fekete Gyorgy
Kadasi Ludovit
Friedman Ken
Schwarz Martin
Bombieri Cristina
Pignatti Pier Franco
Kanavakis Emmanuel
Tzetis Maria
Schwartz Marianne
Novelli Giuseppe
D'Apice Maria Rosaria
Sobczynska-Tomaszewska Agnieszka
Bal Jerzy
Stuhrmann Manfred
Macek Milan
Claustres Mireille
Cutting Garry R
References (10)
10 references, click to expand
  1. Linkage disequilibrium between the M470V variant and the IVS8 polyT alleles of the CFTR gene in CBAVD.
    J Med Genet. 1998 Jul;35(7):594-6 PMID: 9678705
  2. Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9.
    Hum Mol Genet. 1999 Dec;8(13):2339-49 PMID: 10556281
  3. Lung disease associated with the IVS8 5T allele of the CFTR gene.
    Am J Respir Crit Care Med. 2000 Nov;162(5):1919-24 PMID: 11069835
  4. Cystic fibrosis screening using the College panel: platform comparison and lessons learned from the first 20,000 samples.
    Genet Med. 2002 Jul-Aug;4(4):289-96 PMID: 12172395
  5. A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing.
    Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3504-9 PMID: 14993601
  6. Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA.
    Nat Genet. 1993 Feb;3(2):151-6 PMID: 7684646
  7. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens.
    N Engl J Med. 1995 Jun 1;332(22):1475-80 PMID: 7739684
  8. CFTR gene variant for patients with congenital absence of vas deferens.
    Am J Hum Genet. 1995 Oct;57(4):958-60 PMID: 7573058
  9. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation.
    J Clin Invest. 1998 Jan 15;101(2):487-96 PMID: 9435322
  10. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel.
    J Pediatr. 1998 Apr;132(4):589-95 PMID: 9580754
Article Info
Journal
American journal of human genetics
Abbr.
Am J Hum Genet
ISSN
0002-9297
Published
2004-01-00
Epub
2003-00-18
Pages
176-9
Language
English
Region
United States
NLM ID
0370475
PMCID
PMC1181905
Subset
IM
Grants
NHLBI NIH HHS · HL68927 · United States
NHLBI NIH HHS · R01 HL068927 · United States
NIDDK NIH HHS · R37 DK044003 · United States
NIDDK NIH HHS · DK44003 · United States
NIDDK NIH HHS · R01 DK044003 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com